Clinical Trials Logo

Contraception clinical trials

View clinical trials related to Contraception.

Filter by:

NCT ID: NCT03197961 Completed - Contraception Clinical Trials

Pharmacokinetics and Pharmacodynamics of DMPA With HIV PrEP

DynamoPrEP
Start date: November 17, 2017
Phase: Early Phase 1
Study type: Interventional

This study is a biphasic steady state pharmacokinetic and pharmacodynamic study of TFV and FTC in healthy women comparing the drug levels and activity in the absence (first phase) and then the presence (second phase) of DMPA. The investigators will recruit 12 healthy women aged 18-45 who are HIV-negative and at low risk for acquiring HIV.

NCT ID: NCT03187392 Active, not recruiting - Contraception Clinical Trials

Pain Relief for Birth Control Implants Insertion

Start date: June 12, 2017
Phase: Phase 3
Study type: Interventional

The aim of our study is to compare the analgesic effect of topical application of lidocaine-prilocaine cream and lidocaine infiltration during insertion of birth control implants

NCT ID: NCT03182140 Completed - Contraception Clinical Trials

KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method

KYSS
Start date: July 6, 2017
Phase:
Study type: Observational

The main goal of this non-interventional study (NIS) is to evaluate user satisfaction with Kyleena in a real-life setting and to identify factors which influence user satisfaction, taking into account previously used contraceptive methods and reasons for use of Kyleena.

NCT ID: NCT03166111 Completed - Contraception Clinical Trials

Lidocaine In-situ Gel Prior to Intrauterine Device Insertion in Women With no Previous Vaginal Delivery

Start date: September 1, 2017
Phase: Phase 3
Study type: Interventional

Long-acting reversible contraception methods are highly effective methods for reduction of the unplanned pregnancy rate worldwide. The intrauterine device is a single procedure that provides reliable, effective and long term contraception for many women. However, the insertion procedure can be associated with a troublesome degree of pain that prevent some women from choosing its use. Different interventions have been described to decrease pain perception during intrauterine device insertion with no agreement on an effective one. Pre-insertion oral ibuprofen, diclofenac, nitroprusside, local anesthetics as lidocaine and prostaglandins has been reported with variable degrees of success .

NCT ID: NCT03165838 Completed - Pregnancy Related Clinical Trials

Effectiveness of Shortened Time Interval to Postpartum Visit in Improving Postpartum Attendance

Start date: November 18, 2013
Phase: N/A
Study type: Interventional

Due to potential to improve family planning, clinicians are increasingly interested in shortening the time to postpartum visits, but lack an evidence base to change policy.There are no studies that have examined the effectiveness of shortened interval to postpartum visit on attendance rate, contraception use, and rapid repeat of pregnancy (RROP). With this research, the investigators propose to conduct a randomized controlled trial (RCT) to examine the effect of reduced time interval to postpartum visit (3-4 weeks rather than 6-8 weeks) on postpartum visit attendance rate, contraceptive use, and RROP.

NCT ID: NCT03154125 Completed - Contraception Clinical Trials

Sayana® Press Extension Study

Start date: September 22, 2017
Phase: Phase 3
Study type: Interventional

This is a randomized clinical trial designed to evaluate the effectiveness, safety and acceptability of Sayana® Press when injected every 4 months (17-18 weeks) for 3 treatment cycles (12 months) of use.

NCT ID: NCT03153644 Completed - Contraception Clinical Trials

Improving Contraceptive Care for Women With Medical Conditions

Start date: September 7, 2017
Phase:
Study type: Observational

The purpose of this project is to describe how contraceptive services are currently being delivered to women with medical conditions who seek care in community-based primary care settings, such as family medicine and internal medicine clinical offices.

NCT ID: NCT03140800 Not yet recruiting - Contraception Clinical Trials

Use Sonography in Patients With Intrauterine Device Presenting With Bleeding

Start date: June 2017
Phase: N/A
Study type: Observational

Intrauterine contraceptive device is one of the most efficient and reversible methods of birth control with low cost and long duration of use However, in the first year after insertion, between 5 and 15% of women will have their Intrauterine contraceptive device removed because of irregular uterine bleeding which have been attributed to the effect of contact between the device and the endometrium and even the pressure on the uterine muscle . The disharmonious relationship between the Intrauterine contraceptive device and the uterus is the cause of most of the bleeding complaints, so bleeding is related to improper position rather than the contraceptive method itself which should be excluded before abandoning the Intrauterine contraceptive device for any other method of birth control

NCT ID: NCT03135431 Completed - Contraception Clinical Trials

Opportunistic Salpingectomy for Permanent Sterilization at the Time of Cesarean Delivery

Start date: May 17, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the safety of performing a bilateral tubal ligation vs. bilateral salpingectomy, two procedures performed for permanent sterilization, at the time of cesarean delivery. The investigators want to determine if performing bilateral salpingectomy at the time of cesarean delivery poses any greater risk for blood loss, as compared to a bilateral tubal ligation.

NCT ID: NCT03127722 Active, not recruiting - Contraception Clinical Trials

Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization

Start date: May 3, 2017
Phase: N/A
Study type: Interventional

This study is designed to assess post-procedural outcomes for women who chose to undergo either hysteroscopic sterilization (Essure®) or laparoscopic tubal sterilization, including: - Pelvic and/or lower abdominal pain - Abnormal uterine bleeding - Surgical intervention (including "insert removal" and hysterectomy) - Allergic, hypersensitivity, or autoimmune-like reactions